Avocatin B: Its Role in Cancer and Diabetes Mellitus Treatment

Aslı Melike Ekmekçi,Arzu Kasabalı, Oytun Erbaş

DOI: 10.5606/jebms.2023.1039

Issue: 2023, Volume 4 - Issue 1
862 845

The Metabolic Syndrome: A Cancer Risk Factor?

Ayça Nur Demir, Kerem Can Tunç, Mehtap Odabaşı, Oytun Erbaş

DOI: 10.5606/jebms.2023.1040

Issue: 2023, Volume 4 - Issue 1
282 325

Emerging Immunotherapeutic Approaches for Managing Metastasis

Alper Demirezen, Oytun Erbaş

DOI: 10.5606/jebms.2023.1050

Issue: 2023, Volume 4 - Issue 2
238 280

Nasopharyngeal Carcinoma: Causes and Incidence

Fatih Özgür Sarıbıyık, Oytun Erbaş

DOI: 10.5606/jebms.2023.1060

Issue: 2023, Volume 4 - Issue 3
151 138

Regulatory T Cells and Their Implications in Cancer Immunotherapy

Saime Sıla Gemici, Oytun Erbaş

DOI: 10.5606/jebms.2023.1064

Issue: 2023, Volume 4 - Issue 3
125 152

Cancer Stem Cells

Alper Demirezen, Oytun Erbaş

DOI: 10.5606/jebms.2024.1083

Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
65 105

Stem Cell Therapy in Cancer

Ayça Nur Demir, Oytun Erbaş

DOI: 10.5606/jebms.2024.1084

Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
74 98